标题
New and emerging targeted systemic therapies: a new era for atopic dermatitis
作者
关键词
-
出版物
JOURNAL OF DERMATOLOGICAL TREATMENT
Volume 29, Issue 4, Pages 364-374
出版商
Informa UK Limited
发表日期
2017-08-31
DOI
10.1080/09546634.2017.1373736
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- JTE-852, a novel spleen tyrosine kinase inhibitor, blocks mediator secretion from mast cells with immunoglobulin E crosslinking
- (2017) Toshinobu Kato et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- 313 A pathogenic role for Th22/IL-22 in atopic dermatitis is established by a placebo-controlled trial with an anti IL-22/ILV-094 mAb
- (2017) E. Guttman-Yassky et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- The Molecular Revolution in Cutaneous Biology: Investigating the Skin Microbiome
- (2017) Heidi H. Kong et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- The International TREatment of ATopic Eczema (TREAT) Registry Taskforce: An Initiative to Harmonize Data Collection across National Atopic Eczema Photo- and Systemic Therapy Registries
- (2017) Phyllis I. Spuls et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Lebrikizumab improves patient-reported outcomes (PROs) in a phase 2 study in patients with atopic dermatitis
- (2017) JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- A phase 2b dose-ranging efficacy and safety study of tralokinumab in adult patients with moderate to severe atopic dermatitis (AD)
- (2017) JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Ustekinumab treatment in severe atopic dermatitis: Down-regulation of T-helper 2/22 expression
- (2017) Doris Weiss et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- JAK inhibitors in dermatology: The promise of a new drug class
- (2017) William Damsky et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial
- (2017) Andrew Blauvelt et al. LANCET
- Anti–Interleukin-31 Receptor A Antibody for Atopic Dermatitis
- (2017) Thomas Ruzicka et al. NEW ENGLAND JOURNAL OF MEDICINE
- Total IL-12 Levels are Increased in Paediatric Atopic Dermatitis: Correlations with Age and Disease Severity
- (2017) D. Piancatelli et al. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
- Efficacy and safety of ustekinumab treatment in adults with moderate-to-severe atopic dermatitis
- (2016) Saakshi Khattri et al. EXPERIMENTAL DERMATOLOGY
- Omalizumab for atopic dermatitis: case series and a systematic review of the literature
- (2016) Jesper Grønlund Holm et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Efficacy and safety of multiple doses of QGE031 (ligelizumab) versus omalizumab and placebo in inhibiting allergen-induced early asthmatic responses
- (2016) Gail M. Gauvreau et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- 224 Successful use of secukinumab in an Asian patient with severe refractory atopic dermatitis
- (2016) S. Noda et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Comparative effectiveness of biologic agents for the treatment of psoriasis in a real-world setting: Results from a large, prospective, observational study (Psoriasis Longitudinal Assessment and Registry [PSOLAR])
- (2016) Bruce E. Strober et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial
- (2016) Diamant Thaçi et al. LANCET
- Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
- (2016) Eric L. Simpson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Past, present, and future for biologic intervention in atopic dermatitis
- (2015) M. D. Howell et al. ALLERGY
- Pathogenesis of atopic dermatitis
- (2015) W. Peng et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Current novel approaches in systemic therapy of atopic dermatitis
- (2015) Thomas Werfel et al. Current Opinion in Allergy and Clinical Immunology
- Treatment of recalcitrant atopic dermatitis with the oral Janus kinase inhibitor tofacitinib citrate
- (2015) Lauren L. Levy et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Simultaneous inhibition of JAK and SYK kinases ameliorates chronic and destructive arthritis in mice
- (2015) Alba Llop-Guevara et al. ARTHRITIS RESEARCH & THERAPY
- Distribution of IL-31 and its receptor expressing cells in skin of atopic dermatitis
- (2014) Atsuhiko Kato et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Phase 2a, randomized, double-blind, placebo-controlled, multicenter, parallel-group study of a H4R-antagonist (JNJ-39758979) in Japanese adults with moderate atopic dermatitis
- (2014) Yoko Murata et al. JOURNAL OF DERMATOLOGY
- Guidelines of care for the management of atopic dermatitis
- (2014) Robert Sidbury et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Effects of an Anti-TSLP Antibody on Allergen-Induced Asthmatic Responses
- (2014) Gail M. Gauvreau et al. NEW ENGLAND JOURNAL OF MEDICINE
- New era of biologic therapeutics in atopic dermatitis
- (2013) Emma Guttman-Yassky et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Immunologic Effects of Omalizumab in Children with Severe Refractory Atopic Dermatitis: A Randomized, Placebo-Controlled Clinical Trial
- (2013) Shuba Rajashri Iyengar et al. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
- Efficacy and safety of systemic treatments for moderate-to-severe atopic dermatitis: A systematic review
- (2013) Evelien Roekevisch et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- A sensory neuron–expressed IL-31 receptor mediates T helper cell–dependent itch: Involvement of TRPV1 and TRPA1
- (2013) Ferda Cevikbas et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Anti-IgE therapy and severe atopic dermatitis: A pediatric perspective
- (2013) Jonathan Lacombe Barrios et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- A Pilot Study of an Oral Phosphodiesterase Inhibitor (Apremilast) for Atopic Dermatitis in Adults
- (2012) Aman Samrao et al. ARCHIVES OF DERMATOLOGY
- Efficacy and safety of secukinumab in the treatment of moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled phase II dose-ranging study
- (2012) K.A. Papp et al. BRITISH JOURNAL OF DERMATOLOGY
- Anti-immunoglobulin E in the treatment of refractory atopic dermatitis
- (2012) D. H. Kim et al. CLINICAL AND EXPERIMENTAL DERMATOLOGY
- Discovery and Development of Spleen Tyrosine Kinase (SYK) Inhibitors
- (2012) Rajinder Singh et al. JOURNAL OF MEDICINAL CHEMISTRY
- Guidelines for treatment of atopic eczema (atopic dermatitis) Part II
- (2012) J. Ring et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Targeted treatment of pruritus: a look into the future
- (2011) H.L. Tey et al. BRITISH JOURNAL OF DERMATOLOGY
- IgE, Mast Cells, and Eosinophils in Atopic Dermatitis
- (2011) Fu-Tong Liu et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- Interrupting IL-6–receptor signaling improves atopic dermatitis but associates with bacterial superinfection
- (2011) Alexander A. Navarini et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- A Multicenter, Double-Blind, Randomized, Placebo Controlled Trial of a Neurokinin-1 Receptor Antagonist for Overactive Bladder
- (2010) Tara L. Frenkl et al. JOURNAL OF UROLOGY
- Role of PPAR-gamma in inflammation. Prospects for therapeutic intervention by food components
- (2010) Harry Martin MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
- Targeting the Neurokinin Receptor 1 with Aprepitant: A Novel Antipruritic Strategy
- (2010) Sonja Ständer et al. PLoS One
- Thymic stromal lymphopoietin, OX40-ligand, and interleukin-25 in allergic responses
- (2009) Y.-H. Wang et al. CLINICAL AND EXPERIMENTAL ALLERGY
- IL-22–producing “T22” T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17–producing TH17 T cells
- (2009) Kristine E. Nograles et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- The histamine H4 receptor is functionally expressed on TH2 cells
- (2009) Ralf Gutzmer et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Efficacy of omalizumab in the treatment of atopic dermatitis: A pilot study
- (2008) Lee E. Sheinkopf et al. ALLERGY AND ASTHMA PROCEEDINGS
- A Retrospective Case Series Review of the Peroxisome Proliferator-Activated Receptor Ligand Rosiglitazone in the Treatment of Atopic Dermatitis
- (2008) Ramona Behshad et al. ARCHIVES OF DERMATOLOGY
- Omalizumab for patients with severe and therapy-refractory atopic eczema?
- (2008) Christian Andres et al. CURRENT ALLERGY AND ASTHMA REPORTS
- Correlation of IL-31 serum levels with severity of atopic dermatitis
- (2008) Ulrike Raap et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Anti-CD20 (rituximab) treatment improves atopic eczema
- (2008) Dagmar Simon et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Possible Pathogenic Role of Th17 Cells for Atopic Dermatitis
- (2008) Chizuko Koga et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Atopic Dermatitis
- (2008) Thomas Bieber NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More